NASDAQ:IMCC IM Cannabis (IMCC) Stock Price, News & Analysis → The Tesla Indicator Is Bullish (From WealthPress) (Ad) Free IMCC Stock Alerts $0.61 +0.01 (+0.91%) (As of 09:46 AM ET) Add Compare Share Share Today's Range$0.60▼$0.6150-Day Range$0.30▼$1.1152-Week Range$0.19▼$1.43Volume7,068 shsAverage Volume1.06 million shsMarket Capitalization$8.21 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Get IM Cannabis alerts: Email Address IM Cannabis MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy2.42% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.92Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.72) to ($0.31) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.31 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for IM Cannabis.Read more about IM Cannabis' stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.42% of the float of IM Cannabis has been sold short.Short Interest Ratio / Days to CoverIM Cannabis has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IM Cannabis has recently increased by 16.83%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldIM Cannabis does not currently pay a dividend.Dividend GrowthIM Cannabis does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for IMCC. Previous Next 3.3 News and Social Media Coverage News SentimentIM Cannabis has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.79 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for IM Cannabis this week, compared to 0 articles on an average week.Search Interest5 people have searched for IMCC on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added IM Cannabis to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, IM Cannabis insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 7.68% of the stock of IM Cannabis is held by institutions.Read more about IM Cannabis' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for IM Cannabis are expected to grow in the coming year, from ($0.72) to ($0.31) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of IM Cannabis is -0.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of IM Cannabis is -0.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIM Cannabis has a P/B Ratio of 1.32. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about IM Cannabis' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad The TradingPubLook what happened to Netflix during these “Hotspot Dates”We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… About IM Cannabis Stock (NASDAQ:IMCC)IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.Read More IMCC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IMCC Stock News HeadlinesMay 29 at 8:30 AM | prnewswire.comIM Cannabis Closes Convertible Debenture Offering to Support Accelerated Growth in GermanyMay 16, 2024 | msn.comWeed Stocks Rally After Biden Makes Marijuana Reclassification AnnouncementMay 15, 2024 | benzinga.comFlora Growth Goes Back To Net Loss In Q1, Positive About 'Landmark Reform' In The US, Focuses On EuropeMay 11, 2024 | uk.investing.comEarnings call: IM Cannabis focuses on German market amid regulatory changesMay 8, 2024 | investorplace.comIMCC Stock Earnings: IM Cannabis Misses EPS, Misses Revenue for Q1 2024May 8, 2024 | finanznachrichten.deIM Cannabis Corp.: IM Cannabis Reports First Quarter Financial ResultsMay 8, 2024 | prnewswire.comIM Cannabis Reports First Quarter Financial ResultsMay 1, 2024 | msn.comWhat's Going On With IM Cannabis Stock?May 1, 2024 | investorplace.comWhy Is IM Cannabis (IMCC) Stock Up 49% Today?May 1, 2024 | investorplace.comWhy Is IM Cannabis (IMCC) Stock Up 49% Today?May 1, 2024 | prnewswire.comIM Cannabis to Report First Quarter 2024 Financial Results on Wednesday, May 8th at 9:00am ETApril 29, 2024 | msn.comLawmakers aim to pass marijuana regulations by JuneApril 19, 2024 | investorplace.comPuff, Puff, Invest: 3 Top Cannabis Stock Picks to Celebrate 4/20April 9, 2024 | finanznachrichten.deAegis Capital Corp. Acted as Sole Bookrunner on a $3.23 Million Underwritten Public Offering for Flora Growth Corp.April 9, 2024 | prnewswire.comIM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli MarketApril 1, 2024 | prnewswire.comIMC applauds the April 1st implementation of the new Israeli cannabis regulation, facilitating access for many new patientsMarch 30, 2024 | msn.comGermany to Usher in New Era with Marijuana Legalization Law Effective April 1stMarch 28, 2024 | msn.comRockford man charged with selling crack cocaine, cannabisMarch 28, 2024 | prnewswire.comIM Cannabis Reports 2023 Financial ResultsMarch 25, 2024 | prnewswire.comIMC Expects Accelerated Growth in Germany from the Country's Groundbreaking Cannabis LegalizationMarch 20, 2024 | prnewswire.comIM Cannabis to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 28 at 9:00am ETMarch 18, 2024 | msn.comBusinesses ready to go on Kentucky medical marijuana. Why can't they proceed?February 28, 2024 | finanznachrichten.deIM Cannabis Corp.: IMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy companyFebruary 28, 2024 | finance.yahoo.comKadimastem Takes Another Step Towards Signing the Merger Agreement with Nasdaq Listed IMCCFebruary 28, 2024 | finance.yahoo.comIMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy companySee More Headlines Receive IMCC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IM Cannabis and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/08/2024Today5/28/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & botanicals Sub-IndustryN/A Current SymbolNASDAQ:IMCC CUSIPN/A CIK1792030 Webwww.imcannabis.com Phone972-54-433-1111FaxN/AEmployees95Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.80) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,040,000.00 Net Margins-28.03% Pretax Margin-29.66% Return on Equity-75.51% Return on Assets-24.18% Debt Debt-to-Equity Ratio0.05 Current Ratio0.65 Quick Ratio0.40 Sales & Book Value Annual Sales$36.15 million Price / Sales0.23 Cash FlowN/A Price / Cash FlowN/A Book Value$0.76 per share Price / Book0.80Miscellaneous Outstanding Shares13,390,000Free FloatN/AMarket Cap$8.13 million OptionableNot Optionable Beta0.64 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Marc Lustig M.B.A. (Age 50)M.Sc., Executive Chairman Comp: $94.91kMr. Oren ShusterCEO & DirectorMr. Uri Birenberg (Age 48)Chief Financial Officer Comp: $237.95kMr. Richard BallaChief Executive Officer of AdjupharmAdvocate Michal Lebovitz NissimovGeneral CounselKey CompetitorsMannatechNASDAQ:MTEXUpexiNASDAQ:UPXIParanovus Entertainment TechnologyNASDAQ:PAVSHappiness Development GroupNASDAQ:HAPPBon Natural LifeNYSE:BONView All Competitors IMCC Stock Analysis - Frequently Asked Questions How have IMCC shares performed in 2024? IM Cannabis' stock was trading at $0.3570 on January 1st, 2024. Since then, IMCC stock has increased by 70.2% and is now trading at $0.6075. View the best growth stocks for 2024 here. Are investors shorting IM Cannabis? IM Cannabis saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 208,300 shares, an increase of 16.8% from the April 30th total of 178,300 shares. Based on an average daily trading volume, of 1,510,000 shares, the short-interest ratio is currently 0.1 days. Currently, 2.4% of the company's stock are sold short. View IM Cannabis' Short Interest. When is IM Cannabis' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024. View our IMCC earnings forecast. How were IM Cannabis' earnings last quarter? IM Cannabis Corp. (NASDAQ:IMCC) announced its quarterly earnings results on Wednesday, May, 8th. The company reported ($0.16) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.16). The company earned $8.95 million during the quarter, compared to analysts' expectations of $7.84 million. IM Cannabis had a negative trailing twelve-month return on equity of 75.51% and a negative net margin of 28.03%. When did IM Cannabis' stock split? IM Cannabis's stock reverse split on Wednesday, November 16th 2022. The 1-10 reverse split was announced on Wednesday, November 16th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 16th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of IM Cannabis? Shares of IMCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:IMCC) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWrite this ticker symbol down…StocksToTradeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap Profits4 Cryptos BETTER than BitcoinTrue Market InsidersBill Clinton Backing Biden Replacement???The Freeport SocietyYou won't believe what Citigroup just did to it's depositorsAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IM Cannabis Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.